Filing Flows › Aspira Women's Health (AWHL) › Q1 2026 › vs Q1 2025
Aspira Women's Health (AWHL) Q1 2026 vs Q1 2025 (year over year)
Aspira Women's Health's revenue fell $312K (-14%) from $2.3M in Q1 2025 to $2.0M in Q1 2026.
Aspira Women's Health, Q1 2026: revenue $2.0M (-14% year over year), operating margin -112.0%, net earnings $676K, operating cash flow −$359K. The chart draws each line against Q1 2025, the increases inside each band.
Every line
| Line | Q1 2026 | Q1 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $2.0M | $2.3M | −$312K | -14% |
| Other income, net | $2.9M | $1.4M | $1.5M | +108% |
| Costs & expenses | $4.8M | $5.5M | −$673K | -12% |
| Operating costs | $4.2M | $5.5M | −$1.3M | -24% |
| Net earnings | $676K | −$1.9M | $2.5M | — |
| Cost of revenue | $896K | $719K | $177K | +25% |
| Research & development | $1.2M | $973K | $253K | +26% |
| Sales & marketing | $543K | $1.1M | −$543K | -50% |
| General & admin | $1.5M | $2.7M | −$1.2M | -45% |
| Operating cash sources | $1.1M | $1.4M | −$248K | -18% |
| Depreciation & amortization | $40K | $13K | $27K | +208% |
| Share-based compensation | $42K | $103K | −$61K | -59% |
| Cash used in operations | $359K | $3.1M | −$2.7M | -88% |
| Working capital & other | $1.1M | $1.4M | −$248K | -18% |
Questions
How much did Aspira Women's Health's revenue grow year over year in Q1 2026?
Aspira Women's Health's revenue fell $312K (-14%) from $2.3M in Q1 2025 to $2.0M in Q1 2026.